CIK 0001857044
- Non-accelerated filer
- Smaller reporting company
Indaptus Therapeutics, Inc.
Sign in to watch- Ticker
- INDP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 863158720
- Phone
- +1 646-427-2727
- Business address
- 3 COLUMBUS CIRCLE, 15TH FLOOR, NEW YORK, NY, 10019
- Former names
- Intec Parent Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-12-22 | Sassi Nir Chief Financial Officer | Grant or award | +26,758 | $2.03 | $54K | 26,758 |
| 2025-04-10 | Sassi Nir Chief Financial Officer | Returned to the company · Stock Option (right to buy) | −1,250 | $0.07 | $89 | 0 |
| 2025-04-10 | Sassi Nir Chief Financial Officer | Returned to the company · Stock Option (right to buy) | −1,125 | $0.07 | $80 | 0 |
| 2025-04-10 | Sassi Nir Chief Financial Officer | Returned to the company · Stock Option (right to buy) | −2,500 | $0.07 | $178 | 0 |
| 2025-04-10 | Sassi Nir Chief Financial Officer | Returned to the company · Stock Option (right to buy) | −500 | $0.07 | $36 | 0 |
| 2025-04-10 | Sassi Nir Chief Financial Officer | Returned to the company · Stock Option (right to buy) | −500 | $0.07 | $36 | 0 |
| 2025-04-10 | Sassi Nir Chief Financial Officer | Returned to the company · Stock Option (right to buy) | −41 | $0.07 | $3 | 0 |
| 2025-04-10 | Sassi Nir Chief Financial Officer | Returned to the company · Stock Option (right to buy) | −1,125 | $0.07 | $80 | 0 |
| 2024-10-09 | Sassi Nir Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +75,000 | 75,000 | ||
| 2024-01-22 | Sassi Nir Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2023-01-18 | Sassi Nir Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2022-02-25 | Sassi Nir Chief Financial Officer | Grant or award · Stock Option (right to buy) | +60,000 | 60,000 | ||
| 2021-08-04 | Sassi Nir Chief Financial Officer | Grant or award · Stock Option (right to buy) | +35,000 | 35,000 |
Page 1 of 1 · 13 trades